Post transplant lymphoproliferative disorder
| dc.contributor.author | Cader, Rizna Abdul | |
| dc.contributor.author | Gafor, Halim Abdul | |
| dc.contributor.author | Kong, Norella CT | |
| dc.contributor.author | Mohd, Rozita | |
| dc.date.accessioned | 2013-05-23T12:51:11Z | |
| dc.date.available | 2013-05-23T12:51:11Z | |
| dc.date.issued | 2013-05-23 | |
| dc.description.abstract | Introduction: Post-transplant lymphoproliferative disorder (PTLD) is a recognized complication exclusive to solid organ transplant recipients and carries a high mortality. Methods: We retrospectively reviewed records of all renal transplant recipients under follow up at our institution over the last seven years (2005-2011). We reviewed the patient characteristics, immunosuppression regimen and risk factors for the development of PTLD and its outcomes in our transplant cohort. Results: Four out of 63 patients were diagnosed with PTLD. PTLD was incidentally diagnosed on a transplant biopsy that was performed for an unexplained rise in serum creatinine in three patients. The fourth patient presented with left submandibular lymphadenopathy. Majority presented within 18 months of renal transplantation. After the diagnosis of PTLD on graft biopsy, all patients were fully investigated and two patients had systemic involvement. In the patients with systemic involvement, reduction of immunosuppression and anti B cell therapy with Rituximab was used with good success. The patient with submandibular lymphadenopathy received chemotherapy in addition to reduction of immunosuppression. Three PTLD cases were polyclonal and diagnosed early whereas the fourth case was monoclonal. Conclusion: PTLD can sometimes be incidentally diagnosed on an allograft biopsy performed for rejection. The incidence of PTLD in our centre is higher than reports from other centres but our outcome is good if recognised and treated early. | en |
| dc.identifier.issn | 1611-2156 | |
| dc.identifier.uri | http://hdl.handle.net/2003/30345 | |
| dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-10659 | |
| dc.language.iso | en | de |
| dc.relation.ispartofseries | EXCLI Journal ; Vol. 12, 2013 | en |
| dc.subject | Epstein-Barr virus | en |
| dc.subject | immunosuppression reduction | en |
| dc.subject | post transplant lymphoproliferative disorder | en |
| dc.subject | renal transplantation | en |
| dc.subject.ddc | 610 | |
| dc.title | Post transplant lymphoproliferative disorder | en |
| dc.title.alternative | a case series and review of literature | en |
| dc.type | Text | de |
| dc.type.publicationtype | article | en |
| dcterms.accessRights | open access | |
| eldorado.dnb.zdberstkatid | 2132560-1 |